Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

86.78

-0.73

(-0.83%)

At close: 04:03PM EDT

86.80

+0.02

(+0.02%)

After hours:

07:54PM EDT

Advertisement

Trade prices are not sourced from all markets

All

Zacks
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Merck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to Januvia/Janumet against Viatris, which is looking to market its generic versions of the medicines in the United States
- Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
  Investor's Business Daily
- With Seagen News Lacking, Is Merck Stock A Buy Or A Sell?
  Investor's Business Daily
Zacks
Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK
Roche's (RHHBY) eye drug, Vabysmo and AstraZeneca's (AZN) asthma drug Tezspire get approval in Europe. The FDA approves expanded use of Lilly's (LLY) cancer drug, Retevmo.
- GSK picks up troubled Spero drug for nearly $300M, takes stake in company
  American City Business Journals
- Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
  Zacks
Motley Fool
My Take: 4 Strong Growth Stocks to Buy This Week
Taiwan Semiconductor Manufacturing Company (NYSE: TSM) is one of those beneficiaries. In simplest terms, Taiwan Semiconductor (or TSMC) is a contract chip manufacturer. Despite a weakening economy expected to sap chip sales, analysts expect TSMC to keep growing all the same.

Advertisement